236 related articles for article (PubMed ID: 10998425)
1. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.
Urizar NL; Dowhan DH; Moore DD
J Biol Chem; 2000 Dec; 275(50):39313-7. PubMed ID: 10998425
[TBL] [Abstract][Full Text] [Related]
2. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
3. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
Kast HR; Nguyen CM; Sinal CJ; Jones SA; Laffitte BA; Reue K; Gonzalez FJ; Willson TM; Edwards PA
Mol Endocrinol; 2001 Oct; 15(10):1720-8. PubMed ID: 11579204
[TBL] [Abstract][Full Text] [Related]
5. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
Matsukuma KE; Bennett MK; Huang J; Wang L; Gil G; Osborne TF
J Lipid Res; 2006 Dec; 47(12):2754-61. PubMed ID: 16957179
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor regulates bile acid-amino acid conjugation.
Pircher PC; Kitto JL; Petrowski ML; Tangirala RK; Bischoff ED; Schulman IG; Westin SK
J Biol Chem; 2003 Jul; 278(30):27703-11. PubMed ID: 12754200
[TBL] [Abstract][Full Text] [Related]
7. Identification of DRIP205 as a coactivator for the Farnesoid X receptor.
Pineda Torra I; Freedman LP; Garabedian MJ
J Biol Chem; 2004 Aug; 279(35):36184-91. PubMed ID: 15187081
[TBL] [Abstract][Full Text] [Related]
8. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid transfer protein is regulated by liver X receptors in vivo.
Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC
J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004
[TBL] [Abstract][Full Text] [Related]
10. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
11. Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors.
Mak PA; Kast-Woelbern HR; Anisfeld AM; Edwards PA
J Lipid Res; 2002 Dec; 43(12):2037-41. PubMed ID: 12454263
[TBL] [Abstract][Full Text] [Related]
12. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.
Grober J; Zaghini I; Fujii H; Jones SA; Kliewer SA; Willson TM; Ono T; Besnard P
J Biol Chem; 1999 Oct; 274(42):29749-54. PubMed ID: 10514450
[TBL] [Abstract][Full Text] [Related]
13. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
[TBL] [Abstract][Full Text] [Related]
14. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor.
Laffitte BA; Kast HR; Nguyen CM; Zavacki AM; Moore DD; Edwards PA
J Biol Chem; 2000 Apr; 275(14):10638-47. PubMed ID: 10744760
[TBL] [Abstract][Full Text] [Related]
15. Regulation of complement C3 expression by the bile acid receptor FXR.
Li J; Pircher PC; Schulman IG; Westin SK
J Biol Chem; 2005 Mar; 280(9):7427-34. PubMed ID: 15590640
[TBL] [Abstract][Full Text] [Related]
16. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.
Prieur X; Coste H; Rodriguez JC
J Biol Chem; 2003 Jul; 278(28):25468-80. PubMed ID: 12709436
[TBL] [Abstract][Full Text] [Related]
17. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation.
Zhang Y; Kast-Woelbern HR; Edwards PA
J Biol Chem; 2003 Jan; 278(1):104-10. PubMed ID: 12393883
[TBL] [Abstract][Full Text] [Related]
18. Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein.
Tu AY; Albers JJ
Diabetes; 2001 Aug; 50(8):1851-6. PubMed ID: 11473048
[TBL] [Abstract][Full Text] [Related]
19. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
[TBL] [Abstract][Full Text] [Related]
20. A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids.
Shih DM; Kast-Woelbern HR; Wong J; Xia YR; Edwards PA; Lusis AJ
J Lipid Res; 2006 Feb; 47(2):384-92. PubMed ID: 16269825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
